Yeah, an opportunity to get my ass kicked even further. I bought this POS when it got killed the first time and thought it couldn't fall any further. Guess what - I was wrong! I sold out of this mess this morning at a loss and I'll never touch another biopharma again - they're not worth the nebulous risk/reward profile, particularly now that the FDA has turned into assholes.
News 
Market Data 
Discover 
